Tag:

Ozempic

Novo Nordisk teams up with OpenAI on AI drugs

Novo Nordisk is turning to artificial intelligence to accelerate drug development, announcing a major partnership with OpenAI as competition intensifies in the booming weight-loss market.

14 Apr 2026-10:05
India floods market with low-cost copies of Novo’s drugs

At least six Indian pharmaceutical companies have introduced low-cost versions of Novo Nordisk’s (Novo Nordisk) blockbuster diabetes drug Ozempic and weight-loss medication Wegovy over the weekend, offering treatment at prices up to 70% lower than the original.

23 Mar 2026-20:11
Ozempic may cut health risks in Schizophrenia patients

A new study published in JAMA Psychiatry suggests that Ozempic and similar semaglutide-based drugs may significantly reduce physical health risks for people with schizophrenia. The medication improved blood sugar levels and reduced weight gain—two major problems linked to antipsychotic treatments.

10 Dec 2025-09:40
Novo Nordisk Alzheimer's drug trial fails to meet main goal, shares drop 10%

Novo Nordisk (NOVOb.CO) said on Monday that an older oral version of its semaglutide drug failed to meet its primary endpoint in late-stage trials evaluating whether the medicine could slow cognitive decline in patients with early-stage Alzheimer’s disease, sending the company’s shares down 10%.

24 Nov 2025-16:15
Novo Nordisk reaches medicare pricing deal for Ozempic ingredient

Danish drugmaker Novo Nordisk has agreed on a Medicare pricing deal for semaglutide, the active ingredient in its blockbuster weight-loss and diabetes drugs Ozempic and Wegovy, easing investor concerns over steep U.S. pricing cuts.

05 Nov 2025-14:15